TARGETED SENOLYTIC STRATEGIES
IN THE NEWS

Rubedo collaborates with Cedars-Sinai on senolytic IPF program

Senolytic start-up establishes collaboration with Cedars-Sinai Medical Center to advance idiopathic pulmonary fibrosis program.

  • Published: 7:17 am
READ MORE »

Rubedo featured among top senolytic companies in Nature Biotechnology

Send in the senolytics

Despite early failures in the clinic, the idea of anti-aging therapies that purge the body of dying cells is gaining traction with a raft of startups now focused on senescence.

Valuable review describing the emerging field of therapeutic development targeting senescence biology to treat age-related conditions.

  • Published: 8:20 pm
READ MORE »

Rubedo at Longevity Therapeutics Conference 2021

Join us at LT2021. Rubedo will be contributing with a lecture and a round table.

 

Rubedo Life Sciences CEO, Dr. Marco Quarta, will be Chairman of the Conference

on Day 1  – he will join the Panel Discussion titled

A Therapeutic Revolution Against Aging – Bridging the Gaps & Opportunities

 

On Day 2 – Dr. Quarta will give a lecture on

Higher selectivity and safety of Targeted Senolytcs

  • Published: 9:48 pm
READ MORE »

Internship Opportunities in 2021 at Rubedo

Salaried internship opportunities at Rubedo Life Sciences for 2021-2022

9 month internship – CalPoly CIRM Master Program for Regenerative Medicine

 

Summer Internship – SENS Research Foundation Program

  • Published: 2:11 am
READ MORE »

Ending Age-Related Diseases Conference 2020

Rubedo Life Sciences presents results from its strategy of engineered small molecules to target senescence cells in chronic diseases at Ending Age-Related Diseases Conference

  • Published: 10:15 pm
READ MORE »

info@rubedolife.com

Silicon Valley, CA, USA

Copyright 2020 by Rubedo Life Sciences, inc

Cookie Policy
Terms of Service